BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.92 CNY | +1.96% |
|
+11.85% | -10.47% |
| 04-02 | Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023. | CI |
| 02-29 | Bloomage Biotech Names CFO | MT |
| Sales 2023 | 6.08B 839M 1.15B | Sales 2024 * | 7.5B 1.03B 1.41B | Capitalization | 28.86B 3.98B 5.45B |
|---|---|---|---|---|---|
| Net income 2023 | 587M 81.01M 111M | Net income 2024 * | 873M 120M 165M | EV / Sales 2023 | 5.3 x |
| Net cash position 2023 * | 1.23B 170M 233M | Net cash position 2024 * | 1.15B 158M 216M | EV / Sales 2024 * | 3.7 x |
| P/E ratio 2023 |
54.9
x | P/E ratio 2024 * |
33
x | Employees | 4,318 |
| Yield 2023 * |
0.91% | Yield 2024 * |
1.02% | Free-Float | 29.33% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +1.96% | ||
| 1 week | +11.85% | ||
| Current month | +6.68% | ||
| 1 month | +4.39% | ||
| 3 months | -8.89% | ||
| 6 months | -20.26% | ||
| Current year | -10.47% |
1 week
53.20
60.02
1 month
52.8460.02
Current year
50.2269.48
1 year
50.2299.88
3 years
50.22314.99
5 years
50.22314.99
10 years
50.22314.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yan Zhao
CEO | Chief Executive Officer | 57 | 02-12-31 |
Yi Zheng Luan
DFI | Director of Finance/CFO | 39 | 19-12-12 |
Xue Ping Guo
CTO | Chief Tech/Sci/R&D Officer | 59 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yan Zhao
CEO | Chief Executive Officer | 57 | 02-12-31 |
Jia Jun Guo
BRD | Director/Board Member | 49 | 18-03-31 |
Ai Hua Liu
PRN | Corporate Officer/Principal | 61 | 16-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.84% | 1 M€ | -10.23% | - | |
| 1.36% | 45 M€ | -13.85% | - | |
| 1.36% | 45 M€ | -13.26% | - | |
| 1.36% | 39 M€ | -11.99% | - | |
| 0.74% | 2 M€ | -16.59% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 59.92 | +1.96% | 2,383,502 |
| 24-04-25 | 58.77 | +1.01% | 1,269,070 |
| 24-04-24 | 58.18 | +0.36% | 1,344,321 |
| 24-04-23 | 57.97 | +0.10% | 2,611,610 |
| 24-04-22 | 57.91 | +8.10% | 4,337,974 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
59.92
CNY
Average target price
83.72
CNY
Spread / Average Target
+39.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.47% | 3.98B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- 688363 Stock
